4//SEC Filing
REED VICKIE S 4
Accession 0001214659-22-000858
CIK 0001576263other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 8:34 PM ET
Size
9.4 KB
Accession
0001214659-22-000858
Insider Transaction Report
Form 4
REED VICKIE S
SVP, Chief Accounting Officer
Transactions
- Award
Common Stock
2022-01-14+5,377→ 15,902 total - Award
Employee Stock Option (Right to Buy)
2022-01-14+8,910→ 8,910 totalExercise: $124.31Exp: 2032-01-13→ Common Stock (8,910 underlying) - Sale
Common Stock
2022-01-18$120.48/sh−533$64,217→ 15,369 total
Footnotes (4)
- [F1]Grant of Restricted Stock Units (RSUs). Shares will vest 25% annually on the anniversary of the grant date until fully vested.
- [F2]Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 15, 2021.
- [F3]The price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $120.2091 to $120.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
- [F4]25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested.
Documents
Issuer
Mirati Therapeutics, Inc.
CIK 0001576263
Entity typeother
Related Parties
1- filerCIK 0001405637
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 8:34 PM ET
- Size
- 9.4 KB